Z-1518-2025 Class II Ongoing
FDA device recall Z-1518-2025 was initiated by BioFire Diagnostics, LLC on Feb 27, 2025 and is designated Class II. Reason for recall: Increased risk of control failures and false negative test results with multiplexed nucleic acid test. The recall status is ongoing. Affected quantity: 29 kits.
Recall details
- Product Type
- Devices
- Report Date
- Apr 16, 2025
- Initiation Date
- Feb 27, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29 kits
Product description
FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374
Reason for recall
Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
Distribution pattern
OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel
Code information
UDI: 00815381020314/Lot# 0979424
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1518-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026